JP2023548406A5 - - Google Patents

Info

Publication number
JP2023548406A5
JP2023548406A5 JP2023527693A JP2023527693A JP2023548406A5 JP 2023548406 A5 JP2023548406 A5 JP 2023548406A5 JP 2023527693 A JP2023527693 A JP 2023527693A JP 2023527693 A JP2023527693 A JP 2023527693A JP 2023548406 A5 JP2023548406 A5 JP 2023548406A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
cancer
composition according
oxidase
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023527693A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023548406A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/053155 external-priority patent/WO2022103515A1/en
Publication of JP2023548406A publication Critical patent/JP2023548406A/ja
Publication of JP2023548406A5 publication Critical patent/JP2023548406A5/ja
Pending legal-status Critical Current

Links

JP2023527693A 2020-11-11 2021-10-01 固形がんを処置するための組成物および方法 Pending JP2023548406A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063112447P 2020-11-11 2020-11-11
US63/112,447 2020-11-11
PCT/US2021/053155 WO2022103515A1 (en) 2020-11-11 2021-10-01 Compositions and methods for treating solid cancer

Publications (2)

Publication Number Publication Date
JP2023548406A JP2023548406A (ja) 2023-11-16
JP2023548406A5 true JP2023548406A5 (https=) 2024-09-24

Family

ID=81601629

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023527693A Pending JP2023548406A (ja) 2020-11-11 2021-10-01 固形がんを処置するための組成物および方法

Country Status (10)

Country Link
US (1) US20230398190A1 (https=)
EP (1) EP4243835A4 (https=)
JP (1) JP2023548406A (https=)
KR (1) KR20230106646A (https=)
CN (1) CN116710121A (https=)
AU (1) AU2021379542A1 (https=)
CA (1) CA3196357A1 (https=)
IL (1) IL302683A (https=)
MX (1) MX2023005171A (https=)
WO (1) WO2022103515A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250332226A1 (en) * 2022-04-13 2025-10-30 Exoxemis, Inc. Compositions and methods for treating solid cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486408A (en) * 1981-04-07 1984-12-04 Kiel Johnathan L Insoluble crosslinked cytotoxic oxidase-peroxidase system
WO2007103525A2 (en) * 2006-03-09 2007-09-13 Glanbia Nutritionals (Ireland) Limited Cationic whey protein composition
WO2013009910A2 (en) * 2011-07-11 2013-01-17 Exoxemis, Inc. Eosinophil peroxidase compositions and methods of their use
EP4548978A3 (en) * 2015-01-29 2025-08-06 Oxyrase, Inc. Methods for inhibiting tumor growth
US10213448B2 (en) * 2016-03-25 2019-02-26 Novazoi Theranostics Ethanolamine-based lipid biosynthetic compounds, method of making and use thereof
US20190271703A1 (en) * 2016-10-26 2019-09-05 Duke University Biomarkers and treatments for metastatic cancer

Similar Documents

Publication Publication Date Title
Kusakabe et al. A new antitumor enzyme, L-lysine alpha-oxidase from Trichoderma viride. Purification and enzymological properties.
EP0347890B1 (en) Amino acid nutrient compositions
JP3851273B2 (ja) キレート剤を含む毛髪処理に適当な組成物及び毛髪の酸化損傷を低減する方法
Lindahl et al. Interaction of the cysteine proteinase inhibitor chicken cystatin with papain
CN1240370C (zh) 包括螯合剂和调理剂的氧化组合物及护理毛发的方法
CN1030686C (zh) 营养组合物的制备方法
US4438124A (en) Cysteine delivery system
GR3026072T3 (en) Adolescent dietary composition
JP2023548406A5 (https=)
RU2010150428A (ru) Композиции для усиления антибактериальной активности миелопероксидазы и способы их применения
Kondoh et al. Mechanisms of umami taste preference and aversion in rats
FR2435247A1 (fr) Solution d'amino-acides pour la nutrition par voie intraveineuse
Yano et al. A hydrogen-bonding network modulating enzyme function: asparagine-194 and tyrosine-225 of Escherichia coli aspartate aminotransferase
US4434158A (en) Cysteine delivery system
JPS61247354A (ja) 栄養素組成物
AU784612B2 (en) Selenium-containing pro-drugs for cancer therapy
EP1849466B8 (en) Infusion fluid for treating anemia in dialysis patients
CN1202804C (zh) 单剂型后发泡性氧化染发组合物
JPS568312A (en) Amino acid pharmaceutical preparation
Intaglietta et al. Microvascular perspective of oxygen-carrying and-noncarrying blood substitutes
PT1049487E (pt) Tratamento de porfiria aguda interminente (pai) e outras doencas porfiricas
JP2020111620A5 (https=)
JP2025512366A5 (https=)
Breuille et al. Cysteine and glutathione in catabolic states
JP2019515881A5 (https=)